Navigation Links
Pluristem to Present Two Scientific Posters at the International,Society for Cellular Therapy

NEW YORK--(BUSINESS WIRE)--May 2, 2007 - Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy Company dedicated to the commercialization of products for a variety of indications, announced today that it will present two scientific posters at the 13th Annual Meeting of the International Society for Cellular Therapy (ICST), June 24-27, 2007 in Sydney Australia.

Pluristem CEO and Chairman, Mr. Zami Aberman commented, "We are receiving more attention from the scientific community as our research and development team continues to successfully show how innovative our Placenta eXpanded (PLX) cells are. These PLX cells are mesenchymal stem cells expanded in our proprietary 3D PluriX(TM) Bioreactor System."

Pluristem's presentations are entitled, "Expansions of cord blood (CB) derived unseparated hematopoietic stem cells (HSC) co-cultured with mesenchymal cells growing in three dimensional (3-D) mode" and "Promotion of CD34+ cells engraftment using mesenchymal stromal cells expanded ex vivo in bioreactor containing high-density 3-D culture."

Pluristem will also attend the 2007 BIO International Convention being held at the Boston Convention & Exhibition Center from May 6-9, 2007. BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations.

Mr. Aberman added, "These venues provide us with several opportunities to interact with researchers, laboratory professional, physicians, regulatory specialists, business leaders, investments professionals and business colleagues, all working or interested in the cellular therapy sector."

About Pluristem

Pluristem Life Systems, Inc. is a Company dedicated to the commercialization of non-personalized (allogeneic) stem cell therapy products for the treatment of numerous severe degenerative, malignant and autoimmune disorders.
'"/>




Page: 1 2 3

Related medicine technology :

1. Pluristems PLX Cells Demonstrate Potential to Treat Parkinsons Disease
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:10/8/2008)... LYON, France, Oct. 8 /- Vical Inc...anded clinical data and new nonclinical data,demon...may be broadly,applicable in DNA- and protein-base...ncer vaccines. Alain P. Rolland, Pharm.D., Ph.D., ...nt, will present the data today,Wednesday, Octobe...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- Prometheus L...ny, today announced findings from its,development ...y blood test,for irritable bowel syndrome (IBS). T...expression of particular biomarkers in blood sampl...ation of these biomarkers,combined with a proprie...
(Date:10/7/2008)...Study evaluates the efficacy of new device for det...ssed during colonoscopy, ORLANDO, Fla., Oct. 7 /P...erology Annual Scientific Meeting in Orlando (ACG ... MD presented results from a,multi-institutional c...hird,Eye(R) Retroscope(R), a new device that is de...
(Date:10/7/2008)... Results of FLEXX Trial Presented at the Osteoa...ld Congress, PARSIPPANY, N.J., Oct. 7 /PRNewswire...ed results from the FLEXX Trial of Osteoarthritis ...yaluronate), a highly pure,non-avian high molecula...IA-HA), is superior to intra-articular saline (IA-...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Continua Health Alliance Provides Insight Into Next Generation of Digital Health at CONNECTIONS 28TM 29 20074 1Continua Health Alliance Provides Insight Into Next Generation of Digital Health at CONNECTIONS 28TM 29 20074 2North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 1North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 2North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 3Key to Angelina Like Cheeks 3F Add Volume to Deep Fat Compartment 20068 1Key to Angelina Like Cheeks 3F Add Volume to Deep Fat Compartment 20068 2Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 5589 1Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 5589 2Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 5589 3Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 5589 4
(Date:10/10/2008)...e testing is often on those already on drugs, some..., FRIDAY, Oct. 10 (HealthDay News) -- A new study ... Clostridium difficile ( C. difficile ) infections...rchers with McGill University and the Jewish Gener...senior citizens who acquired C. difficile infect...
(Date:10/10/2008)...MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall/ -- ...s that it has appointed William,(Bill) Federici, 4...to five,members., Mr. Federici joined West Pharma...ncial Officer in August of 2003. Under his financi... grown to more than $1.0 billion from,$300 million...
(Date:10/10/2008)...RICHMOND, Va., Oct. 10 /PRNewswire/ -- Do you thin...Can,t get around town? Attend the October,17 open ...e Blind and,Vision Impaired, and see how instructo...o lead productive, fulfilling lives through non-vi..., located at 401 Azalea Avenue, is holding an open...
(Date:10/10/2008)... Upon the completion of a hig...vision of CDM Media proudly announces their next b...ief information technology executives in healthcar...it will launch May 10-12, 2009 at the Four Seasons... Honolulu, HI (PRWEB) October 11, 2008 -- Upon ...
Breaking Medicine News(10 mins):Health News:Antibiotics May Not Cause Diarrheal Bacteria 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2
...at awards and accomplishments could have a profoun...car winners have been on an average found to live ...t the race and went home and empty-handed. The in...d actresses can be found in the latest issue of th...
...lular biologist who is the principle investigator ...of taste cells would help them to discover molecul...stes.// Researchers from the Monell Chemical Sense...eceptor cells outside the body. They have also bee...
...ly harms the teeth by way of discoloring them, it ...nal treatment, according to a new study // appeari...earch. "The findings substantiate what most of u...o your health," Elizabeth Krall Kaye, PhD, MPH, ep...
...PhD, with the Bradley Hasbro Children's Research C... effect of asthma on children. She said that // th...ving skills may be less likely to have their asthm...inspite of facing the stress related to urban scen...
Other Medicine News:Health News:Oscar Winners Live Longer Than Co-Competitors 2Health News:Functional Taste Cells Cultured In Vitro 2
...ragon CZE 2000 Capillary Electrophoresis System us...erum protein electrophoresis (SPE), urine protein ...ctrophoresis (IFE/s) for fast and accurate analysi... no sample preparation and no staining to process ...
The CellTracks® Analyzer II is a semi-automated fluorescence microscope used to enumerate fluorescently labeled cells that are immunomagnetically selected and aligned. The product consists of the
These unique Acid Fast Control Slides simulate a clinical sputum smear with appropriate background material. Slides have two wells containing a positive and negative smear. Can be used with Kinyoun (
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques.
Medicine Products: